Ester Baiget, President & CEO: “I’m happy to announce that Amy Byrick will join our Executive Leadership Team as EVP of Strategy & Business Transformation. Amy has strong cross-functional leadership capabilities and a solid track-record of driving operational simplification with a focus on empowerment and agile cultures and mindsets. She has the right strategic and commercial profile with extensive marketdriven business experience. Her capabilities will be instrumental in our collective effort to become a more customer-centric company with better commercial capabilities and a portfolio diversification that drives higher, sustainable growth. I’m confident Amy is the right person to advance our strategy and transform our business for the world of tomorrow.”

Amy Byrick joins Novozymes from DuPont Nutrition & Biosciences, where she led the Global Food & Beverage business. Prior to her time at DuPont, Amy spent more than a decade at Amcor holding various strategic, marketing and general management positions. Amy holds both Canadian and French nationalities and resides in Denmark. She holds a bachelors degree in Chemical Engineering from Queen’s University and an MBA from INSEAD.

Amy Byrick, newly appointed Executive Vice President of Strategy & Business Transformation: “I’m very excited to join Novozymes. The company’s unique capabilities and technology, and its aspiration to enable sustainable solutions to meet evolving global needs, is something that I find immensely inspiring. I look forward to joining the team and growing the business.”

Thomas Videbæk, who is the interim EVP of Strategy & Business Transformation, will transition this role to Amy. The aim is for the transition to take place during the second quarter of 2021. Thomas will continue in his role as interim EVP of People, Sustainability & Brand until his successor is appointed and established in the role.

The appointment has no impact on the financial outlook for 2020.